Featured series 
Tag: HIV
-
Nation & World
Scientists identify HIV patient whose body rids itself of virus
A second untreated person living with HIV shows no evidence of intact HIV genomes, indicating that her immune system may have eliminated the HIV reservoir.
-
Nation & World
AI can help reduce the risk of HIV in high-risk communities
Researchers have developed an AI system that can identify the people within a social network who can most effectively promote information about HIV prevention to their peers.
-
Nation & World
‘When you see death all the time, you go into this mode of increased energy and sharper focus’
Pioneering AIDS researcher Myron “Max” Essex was one of the first to propose that a retrovirus was the cause of AIDS.
-
Nation & World
Ending HIV transmission by 2030
Eradicating the remaining pockets of HIV transmission in the U.S. by 2030 will be a challenge for the Trump administration, and depend on local cooperation in reaching high-risk groups with surveillance, prevention, and treatment, according to Harvard HIV/AIDS researcher Max Essex.
-
Nation & World
Harvard licenses genotyping platform
Harvard University has granted a license to Aldatu Biosciences Inc., an early-stage diagnostics development company, for a novel genotyping platform that may help clinicians treating HIV to determine more quickly the most effective medication for each patient.
-
Nation & World
A promising strategy against HIV
Harvard Stem Cell Institute researchers at Massachusetts General and Boston Children’s hospitals for the first time have used a relatively new gene-editing technique to create what could prove to be an effective technique for blocking HIV from invading and destroying patients’ immune systems.
-
Nation & World
Viral load as an anti-AIDS hammer
Harvard researchers have joined with counterparts in the U.S. and Botswana governments to conduct a major evaluation of AIDS treatment targeted specifically to reduce infectivity.
-
Nation & World
Toward an AIDS-free generation
AIDS researchers and medical ethicists gathered at the Harvard School of Public Health to explore possible ethical issues affecting studies of promising strategies to fight the ailment.
-
Nation & World
In Africa, success against AIDS
AIDS researchers gathered at the Harvard School of Public Health to mark 10 years of work under a landmark federal anti-AIDS program that has led to significant progress against the epidemic.
-
Nation & World
TB test offers rapid results
A new rapid test for tuberculosis (TB) could substantially and cost-effectively reduce TB deaths and improve treatment in southern Africa — a region where both HIV and tuberculosis are common — according to a new study by Harvard School of Public Health researchers
-
Nation & World
When parasites catch viruses
Researchers have found that a protozoan parasite causing an STD that affects a quarter of a million people yearly is fueled in part by its own viral symbiont. Antibiotics that simply kill the parasite are not the solution.
-
Nation & World
Forward thinking on HIV
A research team led by Martin Nowak has developed a technique for modeling the effects of various HIV treatments and for predicting whether the treatments will cause the virus to develop resistance.
-
Nation & World
The problem of pre-existing mutations
In a critical step that may lead to more-effective HIV treatments, Harvard scientists have found that, in a small number of HIV patients, pre-existing mutations in the virus can cause it to develop resistance to the drugs used to slow the progression of the disease.
-
Nation & World
Organizing for health care
Pedrag Stojicic, who is graduating from the Harvard School of Public Health, plans to apply his passion for organizing to problems in his Serbian homeland, including HIV/AIDS and physician corruption.
-
Nation & World
Ragon study is honored
A study by researchers at the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard is among those chosen to receive Top 10 Clinical Research Achievement Awards from the Clinical Research Foundation.
-
Nation & World
Self-assembly as a guide
Vinothan Manoharan, an assistant professor of chemical engineering and physics at the School of Engineering and Applied Sciences, wants to make self-assembly — when particles interact with one another and spontaneously arrange themselves into organized structures — happen in the laboratory to treat life-threatening diseases or manufacture useful objects.
-
Nation & World
Cells that kill HIV-infected cells
Harvard researchers find that a subpopulation of the immune cells targeted by HIV may play an important role in controlling viral loads after initial infection, potentially helping to determine how quickly infection will progress.
-
Nation & World
Triumphs against smallpox, polio, AIDS
Harvard researchers have been at the forefront of many battles against devastating diseases, leading pivotal breakthroughs against scourges from 1800 to the present.
-
Nation & World
Plotting the demise of AIDS
Hundreds of scientists, activists, doctors, and others who have been on the front lines battling the HIV virus, gathered on Harvard’s Longwood campus for a conference reflecting on progress against the ailment, while rededicating themselves to end the epidemic.
-
Nation & World
HIV prevention gets $20M boost
A new four-year, $20 million grant from the U.S. Centers for Disease Control and Prevention (CDC) will enable Harvard School of Public Health (HSPH) researchers to evaluate the impact and cost-effectiveness of a unique combination of HIV prevention strategies in Botswana.
-
Nation & World
Tanzania-HSPH AIDS clinic opens
U.S. and Tanzanian government officials opened a new research and treatment center for Tanzania’s sickest AIDS patients Friday (July 22), to be operated by Tanzanian health officials in partnership with the Harvard School of Public Health.
-
Nation & World
A focus on battling tuberculosis
Scientists from around New England gathered at the Broad Institute of MIT and Harvard to discuss the latest research and findings about tuberculosis at the Fifth Annual New England Tuberculosis Symposium.
-
Nation & World
Kavanagh receives grant for HIV research
Daniel G. Kavanagh, a member of the faculty at the Ragon Institute, is one of the winners of the Bill & Melinda Gates Foundation’s Grand Challenges Explorations initiative.
-
Nation & World
Protein that helps battle HIV
Harvard researchers at Massachusetts General Hospital and the Ragon Institute of MGH, MIT and Harvard find that elevated levels of p21, a protein best known as a cancer fighter, may be involved in the immune system’s ability to control HIV infection.
-
Nation & World
Keeping HIV out of the cradle
A Harvard School of Public Health AIDS Initiative trial that gave HIV-positive mothers in Botswana antiretroviral drugs during the months after birth showed a dramatic reduction in the transmission of the virus from mothers to breast-fed babies.
-
Nation & World
Hope for AIDS vaccine?
Progress on several fronts has raised optimism about the possibility of achieving an effective AIDS vaccine in the coming years, a speaker at the Harvard School of Public Health said Tuesday (Nov. 9).
-
Nation & World
Sex work in Asia
Conference on “Sex Work in Asia,” hosted by the Harvard University Asia Center and Harvard Medical School, discusses issue involving more than 8 million people.
-
Nation & World
The immune system and HIV
Researchers gather to share information about the latest advances in understanding how the oldest part of the body’s immune system might help in the fight against HIV and AIDS.
-
Nation & World
Bjork named Marshall Scholar
Harvard senior Samuel Bjork has won a prestigious Marshall Scholarship, allowing him to study for two years in the United Kingdom at the university of his choice.
-
Nation & World
Search for new tuberculosis drugs outlined
A new drug candidate that attacks the cell walls of tuberculosis bacteria offers a promising alternative in the fight against a disease that has been resurgent in the global age of AIDS, according to findings highlighted by a key researcher Friday (June 12) at the Broad Institute of Harvard and MIT.